Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;15(2):81-95.
doi: 10.1038/nrgastro.2017.146. Epub 2017 Nov 29.

Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics

Affiliations
Review

Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics

Nina Frey et al. Nat Rev Gastroenterol Hepatol. 2018 Feb.

Abstract

Senescence is a durable cell cycle arrest that can be induced in response to various stress factors, such as telomere erosion, DNA damage or the aberrant activation of oncogenes. In addition to its well-established role as a stress response programme, research has revealed important physiological roles of senescence in nondisease settings, such as embryonic development, wound healing, tissue repair and ageing. Senescent cells secrete various cytokines, chemokines, matrix remodelling proteases and growth factors, a phenotype collectively referred to as the senescence-associated secretory phenotype. These factors evoke immune responses that, depending on the pathophysiological context, can either prevent or even fuel disease and tumorigenesis. Remarkably, even the gut microbiota can influence senescence in various organs. In this Review, we provide an introduction to cellular senescence, addressed particularly to gastroenterologists and hepatologists, and discuss the implications of senescence for the pathogenesis of malignant and nonmalignant gastrointestinal and hepatobiliary diseases. We conclude with an outlook on how modulation of cellular senescence might be used for therapeutic purposes.

PubMed Disclaimer

References

    1. J Neurooncol. 2016 Sep;129(3):443-451 - PubMed
    1. Oncogene. 2014 Mar 20;33(12):1495-505 - PubMed
    1. Nature. 2016 Feb 11;530(7589):184-9 - PubMed
    1. Nat Rev Cancer. 2014 Aug;14(8):547-58 - PubMed
    1. Clin Cancer Res. 2008 Aug 1;14(15):4971-80 - PubMed

Publication types

MeSH terms

LinkOut - more resources